## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de
Aggressive Simultaneous Radiochemotherapy with Cisplatin and Paclitaxel in Combination with Accelerated Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Tumors
✍ Scribed by Thomas Kuhnt; Axel Becker; Steffi Pigorsch; Tanja Pelz; Marc Bloching; Marcus Passmann; Erwin Lotterer; Gabriele Hänsgen; Jürgen Dunst
- Publisher
- Springer
- Year
- 2003
- Tongue
- German
- Weight
- 282 KB
- Volume
- 179
- Category
- Article
- ISSN
- 0179-7158
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Both twice daily fractionated radiotherapy and concurrent cisplatin with once-daily radiotherapy have been shown to improve local disease control in patients with head and neck cancer. the objective of this phase i trial was to determine the maximum tolerated dose of cisplatin which
## Background: The authors undertook a retrospective study on local tumor control, survival, and complications of conventional irradiation compared with accelerated hyperfractionated irradiation in women with selected head and neck tumor sites. ## Methods: One hundred eight consecutive women who